For procurement managers and R&D scientists in the pharmaceutical industry, sourcing high-quality intermediates is paramount to successful drug development and manufacturing. One such crucial compound is ALPHA-(CHLOROMETHYL)-2,4-DICHLOROBENZYL ALCOHOL, identified by its CAS number 13692-14-3. This chemical serves as a vital building block in the synthesis of various Active Pharmaceutical Ingredients (APIs). Understanding its properties and finding a reliable supplier is key to maintaining an efficient and cost-effective production chain.

ALPHA-(CHLOROMETHYL)-2,4-DICHLOROBENZYL ALCOHOL, with the molecular formula C8H7Cl3O, presents specific chemical characteristics that make it valuable in organic synthesis. Its melting point typically falls within the range of 48-52 °C, indicating it is a solid at room temperature, which is advantageous for handling and storage. The presence of chlorine atoms on the benzene ring, along with the chloromethyl and hydroxyl groups, provides reactive sites for further chemical modifications. This makes it an indispensable intermediate for creating complex molecular structures required for new drug candidates.

When looking to buy ALPHA-(CHLOROMETHYL)-2,4-DICHLOROBENZYL ALCOHOL, B2B professionals must prioritize suppliers that offer not only competitive pricing but also guaranteed purity and consistent supply. Manufacturers based in China are often at the forefront of providing such essential chemical intermediates. For companies seeking a dependable ALPHA-(CHLOROMETHYL)-2,4-DICHLOROBENZYL ALCOHOL supplier, partnering with experienced manufacturers ensures adherence to quality standards and regulatory requirements. This availability is critical for both pilot-scale research and large-volume commercial production. Engaging with a reputable manufacturer can provide insights into the optimal conditions for utilizing this intermediate in your specific synthetic pathways.

The chemical synthesis processes that employ ALPHA-(CHLOROMETHYL)-2,4-DICHLOROBENZYL ALCOHOL often demand high levels of purity to avoid unwanted side reactions and ensure the efficacy of the final product. Therefore, verifying the product's specifications, such as its purity level (often cited as ≥95%), is a standard practice for purchasing managers. By securing a consistent supply of this intermediate, pharmaceutical companies can optimize their manufacturing schedules and mitigate risks associated with supply chain disruptions. Exploring various purchase options, including bulk orders, can further enhance cost-effectiveness. Ultimately, a strategic partnership with a trusted chemical manufacturer ensures that your project has access to this essential component for successful innovation.